News and Press Releases

DNA strand for Precision Medicine

News and Press Releases

RPRD Diagnostics and St. Jude Children’s Research Hospital Work Toward Racially Diverse Pharmacogenomics Testing to Meet Goal of Precision Medicine

RPRD (Right Patient Right Drug) Diagnostics, a privately-held, Wisconsin-based precision medicine company, and St. Jude Children’s Research Hospital today announced their recent publication, “Challenges in clinical implementation of CYP2D6 genotyping: choice of variants to test affects phenotype determination,” in Genetics in Medicine, the official journal of the American College of Medical Genetics and Genomics.